Scott D. Kuduk

5.1k total citations
101 papers, 3.7k citations indexed

About

Scott D. Kuduk is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Scott D. Kuduk has authored 101 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 35 papers in Organic Chemistry and 21 papers in Oncology. Recurrent topics in Scott D. Kuduk's work include Receptor Mechanisms and Signaling (18 papers), Cancer Treatment and Pharmacology (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). Scott D. Kuduk is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Cancer Treatment and Pharmacology (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). Scott D. Kuduk collaborates with scholars based in United States, Belgium and France. Scott D. Kuduk's co-authors include Samuel J. Danishefsky, Iwao Ojima, Jacob B. Schwarz, Peter W. Glunz, Dalibor Sameš, Mark G. Bock, Ronald K. Chang, Christina N. Di Marco, Robert M. DiPardo and Jason M. Uslaner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Scott D. Kuduk

101 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott D. Kuduk United States 35 2.0k 1.5k 995 489 380 101 3.7k
George D. Hartman United States 40 2.5k 1.3× 1.7k 1.1× 508 0.5× 600 1.2× 347 0.9× 183 5.4k
Hiroaki Gouda Japan 23 1.5k 0.8× 390 0.3× 172 0.2× 198 0.4× 97 0.3× 84 2.3k
Matthew Elliott United States 16 1.8k 0.9× 324 0.2× 457 0.5× 173 0.4× 285 0.8× 32 2.7k
Mitsuru Ohkubo Japan 23 783 0.4× 631 0.4× 311 0.3× 154 0.3× 97 0.3× 60 1.5k
Philip Jones United States 33 2.7k 1.4× 522 0.3× 1.0k 1.0× 585 1.2× 107 0.3× 92 3.6k
Thomas Kolter Germany 36 3.7k 1.8× 1.5k 1.0× 181 0.2× 215 0.4× 1.1k 2.8× 93 5.2k
Henk Timmerman Netherlands 36 2.4k 1.2× 517 0.3× 405 0.4× 799 1.6× 65 0.2× 112 4.2k
James C. Errey United Kingdom 33 3.3k 1.6× 977 0.7× 253 0.3× 1.2k 2.5× 42 0.1× 45 3.9k
Ku‐Lung Hsu United States 29 1.6k 0.8× 785 0.5× 270 0.3× 284 0.6× 251 0.7× 82 2.7k
Roger Freidinger United States 37 3.5k 1.7× 2.4k 1.6× 665 0.7× 1.1k 2.2× 49 0.1× 121 5.9k

Countries citing papers authored by Scott D. Kuduk

Since Specialization
Citations

This map shows the geographic impact of Scott D. Kuduk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Kuduk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Kuduk more than expected).

Fields of papers citing papers by Scott D. Kuduk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Kuduk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Kuduk. The network helps show where Scott D. Kuduk may publish in the future.

Co-authorship network of co-authors of Scott D. Kuduk

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Kuduk. A scholar is included among the top collaborators of Scott D. Kuduk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Kuduk. Scott D. Kuduk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuduk, Scott D., Bart Stoops, Richard Alexander, et al.. (2021). Identification of a new class of HBV capsid assembly modulator. Bioorganic & Medicinal Chemistry Letters. 39. 127848–127848. 11 indexed citations
2.
Kuduk, Scott D., Angela M. Lam, Christine Espiritu, et al.. (2019). SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators. Bioorganic & Medicinal Chemistry Letters. 29(16). 2405–2409. 12 indexed citations
3.
McDonald, Terrence P., Raul Sanoja, Anthony L. Gotter, et al.. (2016). Pharmacological evaluation of orexin receptor antagonists in preclinical animal models of pain. Journal of Neurogenetics. 30(1). 32–41. 4 indexed citations
4.
Roecker, Anthony J., Swati P. Mercer, Jeffrey M. Bergman, et al.. (2015). Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorganic & Medicinal Chemistry Letters. 25(21). 4992–4999. 14 indexed citations
5.
Kuduk, Scott D., Christina N. Di Marco, Joseph G. Bruno, et al.. (2014). Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexant. Bioorganic & Medicinal Chemistry Letters. 24(7). 1784–1789. 7 indexed citations
6.
Gotter, Anthony L., Susan L. Garson, Joanne Stevens, et al.. (2014). Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators. BMC Neuroscience. 15(1). 109–109. 40 indexed citations
7.
Tannenbaum, Pamela L., Joanne Stevens, Alan T. Savitz, et al.. (2014). Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Frontiers in Behavioral Neuroscience. 8. 182–182. 32 indexed citations
8.
Fox, Steven V., Anthony L. Gotter, Spencer J. Tye, et al.. (2013). Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats. Neuropsychopharmacology. 38(12). 2401–2408. 33 indexed citations
9.
Conn, P. Jeffrey, Scott D. Kuduk, & Darı́o Doller. (2012). Drug Design Strategies for GPCR Allosteric Modulators. PubMed. 47. 441–457. 18 indexed citations
10.
Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2010). N-Heterocyclic derived M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(4). 1334–1337. 25 indexed citations
11.
Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2010). Fused heterocyclic M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 21(9). 2769–2772. 14 indexed citations
12.
Kuduk, Scott D., Robert M. DiPardo, Douglas C. Beshore, et al.. (2010). Hydroxy cycloalkyl fused pyridone carboxylic acid M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(8). 2538–2541. 15 indexed citations
13.
Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2009). Pyridine containing M1 positive allosteric modulators with reduced plasma protein binding. Bioorganic & Medicinal Chemistry Letters. 20(2). 657–661. 20 indexed citations
14.
15.
Kuduk, Scott D., Christina N. Di Marco, Ronald K. Chang, et al.. (2006). 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(10). 2791–2795. 10 indexed citations
16.
Kuduk, Scott D., Ronald K. Chang, Christina Ng, et al.. (2005). Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series. Bioorganic & Medicinal Chemistry Letters. 15(17). 3925–3929. 14 indexed citations
17.
Ojima, Iwao, et al.. (2003). Structure–activity relationship study of taxoids for their ability to activate murine macrophages as well as inhibit the growth of macrophage-like cells. Bioorganic & Medicinal Chemistry. 11(13). 2867–2888. 17 indexed citations
18.
Zheng, Fuzhong F., Scott D. Kuduk, Gabriela Chiosis, et al.. (2000). Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.. PubMed. 60(8). 2090–4. 73 indexed citations
19.
Kuduk, Scott D., Christina R. Harris, Fuzhong F. Zheng, et al.. (2000). Synthesis and evaluation of geldanamycin–testosterone hybrids. Bioorganic & Medicinal Chemistry Letters. 10(11). 1303–1306. 71 indexed citations
20.
Kuduk, Scott D., Fuzhong F. Zheng, Laura Sepp‐Lorenzino, Neal Rosen, & Samuel J. Danishefsky. (1999). Synthesis and evaluation of geldanamycin-estradiol hybrids. Bioorganic & Medicinal Chemistry Letters. 9(9). 1233–1238. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George D. Hartman Breakdown of academic impact, for papers by Hiroaki Gouda Breakdown of academic impact, for papers by Matthew Elliott Breakdown of academic impact, for papers by Mitsuru Ohkubo Breakdown of academic impact, for papers by Philip Jones Breakdown of academic impact, for papers by Thomas Kolter Breakdown of academic impact, for papers by Henk Timmerman Breakdown of academic impact, for papers by James C. Errey Breakdown of academic impact, for papers by Ku‐Lung Hsu Breakdown of academic impact, for papers by Roger Freidinger
Rankless by CCL
2026